With the implementation of the anticipated medical cannabis regulatory reform, the Israeli ministry of health removed many of the heavy regulations in the sector, making medical cannabis more accessible to new patients.
TORONTO and GLIL YAM, Israel, April 1, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, welcomes the implementation of the medical cannabis regulatory reform in Israel on April 1st.
The reform, announced by the Israeli ministry of health on August 7, 2023, underwent a three-month delay due to the Israel-Hamas war following its initial announcement (the “Reform“).
The Reform will be implemented in phases, as approved, and announced by the Israeli Ministry of Health. The key aspects of the initial phase, commencing today, April 1st, are as follows:
- Change in the prescription process: patients with a…
